170 related articles for article (PubMed ID: 11757690)
1. Therapy of PCNSL at the Massachusetts General Hospital with high dose methotrexate and deferred radiotherapy.
Hochberg FH; Tabatabai G
Ann Hematol; 2001; 80 Suppl 3():B111-2. PubMed ID: 11757690
[No Abstract] [Full Text] [Related]
2. Therapeutic management of refractory or relapsed primary central nervous system lymphomas.
Reni M; Ferreri AJ
Ann Hematol; 2001; 80 Suppl 3():B113-7. PubMed ID: 11757691
[TBL] [Abstract][Full Text] [Related]
3. Optimal therapy of primary ocular lymphoma.
Plowman PN; Taylor A; Jackson AS; Lightman S; Pavesio C
Clin Oncol (R Coll Radiol); 2002 Dec; 14(6):521. PubMed ID: 12512978
[No Abstract] [Full Text] [Related]
4. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
5. Salvage treatment with etoposide (VP-16), ifosfamide and cytarabine (Ara-C) for patients with recurrent primary central nervous system lymphoma.
Arellano-Rodrigo E; López-Guillermo A; Bessell EM; Nomdedeu B; Montserrat E; Graus F
Eur J Haematol; 2003 Apr; 70(4):219-24. PubMed ID: 12656744
[TBL] [Abstract][Full Text] [Related]
6. Non-hodgkins lymphoma.
Mead G; Woodcock J; Young C
Clin Evid; 2003 Jun; (9):1-21. PubMed ID: 12967352
[No Abstract] [Full Text] [Related]
7. CA and leukemia group B 9251 protocol.
Zitter K; DeVos D
Radiol Technol; 1997; 68(5):423-5. PubMed ID: 9170185
[No Abstract] [Full Text] [Related]
8. Therapy of primary CNS lymphoma with methotrexate-based chemotherapy and deferred radiotherapy: preliminary results.
Cher L; Glass J; Harsh GR; Hochberg FH
Neurology; 1996 Jun; 46(6):1757-9. PubMed ID: 8649588
[TBL] [Abstract][Full Text] [Related]
9. German-Austrian multicenter trial for aggressive non-Hodgkin lymphomas: COP-BLAM/IMVP-16 chemotherapy with randomized adjuvant radiotherapy.
Gerhartz HH; Thiel E; Brittinger G; Dörken B; Engelhard M; Engert W; Enne W; Fuchs R; Hagen-Aukamp CH; Huhn D
Blut; 1988 Mar; 56(3):139-42. PubMed ID: 2451551
[No Abstract] [Full Text] [Related]
10. Primary non-Hodgkin's lymphoma of the CNS treated with BVAM or CHOD/BVAM chemotherapy before radiotherapy.
Bessell EM; Graus F; Punt JA; Firth JL; Hope DT; Moloney AJ; Lopez-Guillermo A; Villa S
J Clin Oncol; 1996 Mar; 14(3):945-54. PubMed ID: 8622044
[TBL] [Abstract][Full Text] [Related]
11. Combined therapy for primary central nervous system lymphoma in immunocompetent patients.
Ferreri AJ; Reni M; Bolognesi A; Verusio C; Villa E
Eur J Cancer; 1995 Nov; 31A(12):2008-12. PubMed ID: 8562157
[TBL] [Abstract][Full Text] [Related]
12. Primary central nervous system lymphoma (PCNSL) in immunocompetent adults: analysis of a retrospective series of patients treated using idarubicin-containing regimen and radiotherapy.
Vigliotti ML; Dell'Olio M; La Sala A; Romano G; Tartarone A; Mele G; Musto C; Carella AM; Di Renzo N
Hematol J; 2004; 5(5):453-5. PubMed ID: 15448676
[No Abstract] [Full Text] [Related]
13. Central nervous system lymphomas: progress in chemotherapy and radiotherapy.
Brada M
Int J Radiat Oncol Biol Phys; 1995 Oct; 33(3):769-71. PubMed ID: 7558971
[No Abstract] [Full Text] [Related]
14. Mediastinal large-B-cell lymphoma with sclerosis: a clinical study of 21 patients.
Todeschini G; Ambrosetti A; Meneghini V; Pizzolo G; Menestrina F; Chilosi M; Benedetti F; Veneri D; Cetto GL; Perona G
J Clin Oncol; 1990 May; 8(5):804-8. PubMed ID: 1692089
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy as first treatment for primary malignant non-Hodgkin's lymphoma of the central nervous system preliminary data.
Boiardi A; Silvani A; Valentini S; Salmaggi A; Allegranza A; Broggi G
J Neurol; 1993 Dec; 241(2):96-100. PubMed ID: 7511159
[TBL] [Abstract][Full Text] [Related]
16. High-dose sequential (HDS) chemotherapy for high-risk non-Hodgkin's lymphoma: long-term analysis and future developments.
Tarella C; Cuttica A; Caracciolo D; Zallio F; Ricca I; Bergui L; Gavarotti P; Marinone C; Pagano M; Rossi G; de Crescenzo A; Salomone A; Ladetto M; Boccadoro M; Pileri A
Ann Hematol; 2001; 80 Suppl 3():B123-6. PubMed ID: 11757693
[No Abstract] [Full Text] [Related]
17. CHOD/BVAM chemotherapy and whole-brain radiotherapy for newly diagnosed primary central nervous system lymphoma.
Laack NN; O'Neill BP; Ballman KV; O'Fallon JR; Carrero XW; Kurtin PJ; Scheithauer BW; Brown PD; Habermann TM; Colgan JP; Gilbert MR; Hawkins RB; Morton RF; Windschitl HE; Fitch TR; Pajon ER;
Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):476-82. PubMed ID: 20800387
[TBL] [Abstract][Full Text] [Related]
18. Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors.
Bessell EM; Graus F; Lopez-Guillermo A; Lewis SA; Villa S; Verger E; Petit J
Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):501-8. PubMed ID: 15145169
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and outcome of patients with primary CNS lymphoma in a "real-life" setting compared to a clinical trial.
Zeremski V; Koehler M; Fischer T; Schalk E
Ann Hematol; 2016 Apr; 95(5):793-9. PubMed ID: 26801791
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic strategies for aggressive lymphomas: the trials of the DSHNHL.
Schmits R; Glass B; Trümper L; Pfreundschuh M;
Ann Hematol; 2001; 80 Suppl 3():B77-83. PubMed ID: 11757714
[No Abstract] [Full Text] [Related]
[Next] [New Search]
